Dextran-etodolac	dextran-etodolac	O	O	O	O
conjugates	conjugates	O	O	O	O
:	:	O	O	O	O
synthesis	synthesis	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
vitro	vitro	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
evaluation	evaluation	O	O	O	O
.	.	O	O	O	O

Etodolac	etodolac	O	O	OTHERS	I
(	(	O	O	O	O
E	e	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
is	is	O	O	O	O
a	a	O	O	O	O
non-narcotic	non-narcotic	O	O	O	O
analgesic	analgesic	O	O	O	O
and	and	O	O	O	O
antiinflammatory	antiinflammatory	O	O	O	O
drug	drug	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
biodegradable	biodegradable	O	O	O	O
polymer	polymer	O	O	O	O
dextran	dextran	CHEMICALS	O	OTHERS	I
has	has	O	O	O	O
been	been	O	O	O	O
utilized	utilized	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
carrier	carrier	O	O	O	O
for	for	O	O	O	O
synthesis	synthesis	O	O	O	O
of	of	O	O	O	O
etodolac-dextran	etodolac-dextran	O	O	O	O
conjugates	conjugates	O	O	O	O
(	(	O	O	O	O
ED	ed	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
improve	improve	O	O	O	O
its	its	O	O	O	O
aqueous	aqueous	O	O	O	O
solubility	solubility	O	O	O	O
and	and	O	O	O	O
reduce	reduce	O	O	O	O
gastrointestinal	gastrointestinal	O	O	O	O
side	side	O	O	O	O
effects	effects	O	O	O	O
.	.	O	O	O	O

An	an	O	O	O	O
activated	activated	O	O	O	O
moiety	moiety	O	O	O	O
,	,	O	O	O	O
i.e.	i.e.	O	O	O	O
N-acylimidazole	n-acylimidazole	O	O	O	O
derivative	derivative	O	O	O	O
of	of	O	O	O	O
etodolac	etodolac	O	O	OTHERS	I
(	(	O	O	O	O
EAI	eai	O	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
was	was	O	O	O	O
condensed	condensed	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
polysaccharide	polysaccharide	O	O	O	O
polymer	polymer	O	O	O	O
dextran	dextran	CHEMICALS	O	OTHERS	I
of	of	O	O	O	O
different	different	O	O	O	O
molecular	molecular	O	O	O	O
weights	weights	O	O	O	O
(	(	O	O	O	O
40000	40000	O	O	O	O
,	,	O	O	O	O
60000	60000	O	O	O	O
,	,	O	O	O	O
110000	110000	O	O	O	O
and	and	O	O	O	O
200000	200000	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

IR	ir	O	O	O	O
spectral	spectral	O	O	O	O
data	data	O	O	O	O
confirmed	confirmed	O	O	O	O
formation	formation	O	O	O	O
of	of	O	O	O	O
ester	ester	O	O	O	O
bonding	bonding	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
conjugates	conjugates	O	O	O	O
.	.	O	O	O	O

Etodolac	etodolac	O	O	OTHERS	I
contents	contents	O	O	O	O
were	were	O	O	O	O
evaluated	evaluated	O	O	O	O
by	by	O	O	O	O
UV-spectrophotometric	uv-spectrophotometric	O	O	O	O
analysis	analysis	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
molecular	molecular	O	O	O	O
weights	weights	O	O	O	O
were	were	O	O	O	O
determined	determined	O	O	O	O
by	by	O	O	O	O
measuring	measuring	O	O	O	O
viscosity	viscosity	O	O	O	O
using	using	O	O	O	O
the	the	O	O	O	O
Mark-Howink-Sakurada	mark-howink-sakurada	O	O	O	O
equation	equation	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
vitro	vitro	O	O	O	O
hydrolysis	hydrolysis	O	O	O	O
of	of	O	O	O	O
ED	ed	O	O	O	O
was	was	O	O	O	O
done	done	O	O	O	O
in	in	O	O	O	O
aqueous	aqueous	O	O	O	O
buffers	buffers	O	O	O	O
(	(	O	O	O	O
pH	ph	O	O	O	O
1.2	1.2	O	O	O	O
,	,	O	O	O	O
7.4	7.4	O	O	O	O
,	,	O	O	O	O
9	9	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
80	80	O	O	O	O
%	%	O	O	O	O
(	(	O	O	O	O
v/v	v/v	O	O	O	O
)	)	O	O	O	O
human	human	O	O	O	O
plasma	plasma	O	O	O	O
(	(	O	O	O	O
pH	ph	O	O	O	O
7.4	7.4	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

At	at	O	O	O	O
pH	ph	O	O	O	O
9	9	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
higher	higher	O	O	O	O
rate	rate	O	O	O	O
of	of	O	O	O	O
etodolac	etodolac	O	O	OTHERS	I
release	release	O	O	O	O
from	from	O	O	O	O
ED	ed	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
as	as	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
aqueous	aqueous	O	O	O	O
buffer	buffer	O	O	O	O
of	of	O	O	O	O
pH	ph	O	O	O	O
7.4	7.4	O	O	O	O
and	and	O	O	O	O
80	80	O	O	O	O
%	%	O	O	O	O
human	human	O	O	O	O
plasma	plasma	O	O	O	O
(	(	O	O	O	O
pH	ph	O	O	O	O
7.4	7.4	O	O	O	O
)	)	O	O	O	O
,	,	O	O	O	O
following	following	O	O	O	O
first-order	first-order	O	O	O	O
kinetics	kinetics	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
vivo	vivo	O	O	O	O
investigations	investigations	O	O	O	O
were	were	O	O	O	O
performed	performed	O	O	O	O
in	in	O	O	O	O
animals	animals	O	O	O	O
.	.	O	O	O	O

Acute	acute	O	O	O	O
analgesic	analgesic	O	O	O	O
and	and	O	O	O	O
antiinflammatory	antiinflammatory	O	O	O	O
activities	activities	O	O	O	O
were	were	O	O	O	O
ascertained	ascertained	O	O	O	O
using	using	O	O	O	O
acetic	acetic	CHEMICALS	O	OTHERS	I
acid	acid	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
writhing	writhing	O	O	OTHERS	I
model	model	O	O	O	O
(	(	O	O	O	O
mice	mice	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
carrageenan-induced	carrageenan-induced	O	O	O	O
rat	rat	O	O	O	O
paw	paw	O	O	O	O
edema	edema	O	DISEASE	OTHERS	I
model	model	O	O	O	O
,	,	O	O	O	O
respectively	respectively	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
comparison	comparison	O	O	O	O
to	to	O	O	O	O
control	control	O	O	O	O
,	,	O	O	O	O
E	e	O	O	OTHERS	I
and	and	O	O	O	O
ED1-ED4	ed1-ed4	O	O	O	O
showed	showed	O	O	O	O
highly	highly	O	O	O	O
significant	significant	O	O	O	O
analgesic	analgesic	O	O	O	O
and	and	O	O	O	O
antiinflammatory	antiinflammatory	O	O	O	O
activities	activities	O	O	O	O
(	(	O	O	O	O
p	p	O	O	OTHERS	I
<	<	O	O	O	O
0.001	0.001	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Biological	biological	O	O	O	O
evaluation	evaluation	O	O	O	O
suggested	suggested	O	O	O	O
that	that	O	O	O	O
conjugates	conjugates	O	O	O	O
(	(	O	O	O	O
ED1-ED4	ed1-ed4	O	O	O	O
)	)	O	O	O	O
retained	retained	O	O	O	O
comparable	comparable	O	O	O	O
analgesic	analgesic	O	O	O	O
and	and	O	O	O	O
antiinflammatory	antiinflammatory	O	O	O	O
activities	activities	O	O	O	O
with	with	O	O	O	O
remarkably	remarkably	O	O	O	O
reduced	reduced	O	O	O	O
ulcerogenicity	ulcerogenicity	O	O	O	O
as	as	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
their	their	O	O	O	O
parent	parent	O	O	O	O
drug	drug	O	O	O	O
--	--	O	O	O	O
etodolac	etodolac	O	O	OTHERS	I
.	.	O	O	O	O

